Miranda H. Meeuwsen

TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1

Lorenz Jahn, Pleun Hombrink, Renate S. Hagedoorn et al. · Blood · 2017 · 56 citations · Full text

Medicine, Immunology, Oncology +16

Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure

Tassilo L A Wachsmann, Anne K. Wouters, Dennis F.G. Remst et al. · OncoImmunology · 2022 · 55 citations · Full text

Life Sciences, Immunology, Oncology +17

Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S

Tom J. Harryvan, Marten Visser, Linda de Bruin et al. · Journal for ImmunoTherapy of Cancer · 2022 · 39 citations · Full text

Life Sciences, Immunology, Oncology +17

T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion

Laura T. Morton, Tassilo L A Wachsmann, Miranda H. Meeuwsen et al. · Journal for ImmunoTherapy of Cancer · 2022 · 30 citations · Full text

Life Sciences, Immunology, Oncology +17

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer

Rosa A. van Amerongen, Sander Tuit, Anne K. Wouters et al. · Frontiers in Immunology · 2023 · 21 citations · Full text

Life Sciences, Immunology, Oncology +17